This work is licensed under the Creative Commons Attribution 4.0 International License.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209–49. doi: 10.3322/caac.21660SungHFerlayJSiegelRLLaversanneMSoerjomataramIJemalAGlobal Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries2021712094910.3322/caac.21660Open DOISearch in Google Scholar
Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol 2019; 14: 26–38. doi: 10.5114/pg.2018.80001RawlaPBarsoukAEpidemiology of gastric cancer: global trends, risk factors and prevention201914263810.5114/pg.2018.80001Open DOISearch in Google Scholar
Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet 2020; 396: 635–48. doi: 10.1016/s0140-6736(20)31288-5SmythECNilssonMGrabschHIvan GriekenNCLordickFGastric cancer20203966354810.1016/s0140-6736(20)31288-5Open DOISearch in Google Scholar
Lina X, Haiyanga Z, Boa Y, Haia H, Kea Z, Zoub K, et al. Plasma cell-free DNA for screening patients with benefit-assisted neoadjuvant chemotherapy for advanced gastric cancer. ScienceAsia 2020; 46: 462–71. doi: 10.2306/scienceasia1513-1874.2020.056LinaXHaiyangaZBoaYHaiaHKeaZZoubKPlasma cell-free DNA for screening patients with benefit-assisted neoadjuvant chemotherapy for advanced gastric cancer2020464627110.2306/scienceasia1513-1874.2020.056Open DOISearch in Google Scholar
Katai H, Ishikawa T, Akazawa K, Isobe Y, Miyashiro I, Oda I, et al. Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007). Gastric Cancer 2018; 21: 144–54. doi: 10.1007/s10120-017-0716-7KataiHIshikawaTAkazawaKIsobeYMiyashiroIOdaIFive-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007)2018211445410.1007/s10120-017-0716-7Open DOISearch in Google Scholar
Pazin MJ, Kadonaga JT. SWI2/SNF2 and related proteins: ATP-driven motors that disrupt protein-DNA interactions? Cell 1997; 88: 737–40. doi: 10.1016/s0092-8674(00)81918-2PazinMJKadonagaJTSWI2/SNF2 and related proteins: ATP-driven motors that disrupt protein-DNA interactions?1997887374010.1016/s0092-8674(00)81918-2Open DOISearch in Google Scholar
Miyagawa K, Tsuruga T, Kinomura A, Usui K, Katsura M, Tashiro S, et al. A role for RAD54B in homologous recombination in human cells. Embo J 2002; 21: 175–80. doi: 10.1093/emboj/21.1.175MiyagawaKTsurugaTKinomuraAUsuiKKatsuraMTashiroSA role for RAD54B in homologous recombination in human cells2002211758010.1093/emboj/21.1.175Open DOISearch in Google Scholar
Yasuhara T, Suzuki T, Katsura M, Miyagawa K. Rad54B serves as a scaffold in the DNA damage response that limits checkpoint strength. Nat Commun 2014; 5: 5426. doi: 10.1038/ncomms6426YasuharaTSuzukiTKatsuraMMiyagawaKRad54B serves as a scaffold in the DNA damage response that limits checkpoint strength20145542610.1038/ncomms6426Open DOISearch in Google Scholar
Zhang Z, Li X, Han Y, Ji T, Huang X, Gao Q, et al. RAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer. Biomed Pharmacother 2019; 118: 109341. doi: 10.1016/j.biopha.2019.109341ZhangZLiXHanYJiTHuangXGaoQRAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer201911810934110.1016/j.biopha.2019.109341Open DOISearch in Google Scholar
Feng S, Liu J, Hailiang L, Wen J, Zhao Y, Li X, et al. Amplification of RAD54B promotes progression of hepatocellular carcinoma via activating the Wnt/β-catenin signaling. Transl Oncol 2021; 14: 101124. doi: 10.1016/j.tranon.2021.101124FengSLiuJHailiangLWenJZhaoYLiXAmplification of RAD54B promotes progression of hepatocellular carcinoma via activating the Wnt/β-catenin signaling20211410112410.1016/j.tranon.2021.101124Open DOISearch in Google Scholar
Xu C, Liu D, Mei H, Hu J, Luo M. Knockdown of RAD54B expression reduces cell proliferation and induces apoptosis in lung cancer cells. J Int Med Res 2019; 47: 5650–9. doi: 10.1177/0300060519869423XuCLiuDMeiHHuJLuoMKnockdown of RAD54B expression reduces cell proliferation and induces apoptosis in lung cancer cells2019475650910.1177/0300060519869423Open DOISearch in Google Scholar
Nagai Y, Yamamoto Y, Yasuhara T, Hata K, Nishikawa T, Tanaka T, et al. High RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patients. Oncotarget 2015; 6: 21064–73. doi: 10.18632/oncotarget.4222NagaiYYamamotoYYasuharaTHataKNishikawaTTanakaTHigh RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patients20156210647310.18632/oncotarget.4222Open DOISearch in Google Scholar
Amaral T, Schulze M, Sinnberg T, Nieser M, Martus P, Battke F, et al. Are pathogenic germline variants in metastatic melanoma associated with resistance to combined immunotherapy? Cancers 2020; 12. doi: 10.3390/cancers12051101AmaralTSchulzeMSinnbergTNieserMMartusPBattkeFAre pathogenic germline variants in metastatic melanoma associated with resistance to combined immunotherapy?20201210.3390/cancers12051101Open DOISearch in Google Scholar
Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res 2019; 47: W556–60. doi: 10.1093/nar/gkz430TangZKangBLiCChenTZhangZGEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis201947W5566010.1093/nar/gkz430Open DOISearch in Google Scholar
Deng T, Zhong P, Lou R, Yang, X. RNF220 promotes gastric cancer growth and stemness via modulating the USP22/wnt/β-catenin pathway. Tissue Cell 2023; 83: 102123. doi: 10.1016/j.tice.2023.102123DengTZhongPLouRYangXRNF220 promotes gastric cancer growth and stemness via modulating the USP22/wnt/β-catenin pathway20238310212310.1016/j.tice.2023.102123Open DOISearch in Google Scholar
Matsuoka T, Yashiro M. Biomarkers of gastric cancer: Current topics and future perspective. World J Gastroenterol 2018; 24: 2818–32. doi: 10.3748/wjg.v24.i26.2818MatsuokaTYashiroMBiomarkers of gastric cancer: Current topics and future perspective20182428183210.3748/wjg.v24.i26.2818Open DOISearch in Google Scholar
McAndrew EN, McManus KJ. The enigmatic oncogene and tumor suppressor-like properties of RAD54B: Insights into genome instability and cancer. Genes Chromosomes Cancer 2017; 56: 513–23. doi: 10.1002/gcc.22458McAndrewENMcManusKJThe enigmatic oncogene and tumor suppressor-like properties of RAD54B: Insights into genome instability and cancer2017565132310.1002/gcc.22458Open DOISearch in Google Scholar
Wang M, Liao J, Tan C, Zhou H, Wang J, Wang K, et al. Integrated study of miR-215 promoting breast cancer cell apoptosis by targeting RAD54B. J Cell Mol Med 2021; 25: 3327–38. doi: 10.1111/jcmm.16402WangMLiaoJTanCZhouHWangJWangKIntegrated study of miR-215 promoting breast cancer cell apoptosis by targeting RAD54B20212533273810.1111/jcmm.16402Open DOISearch in Google Scholar
Wang R, Li Y, Chen Y, Wang L, Wu Q, Guo Y, et al. Inhibition of RAD54B suppresses proliferation and promotes apoptosis in hepatoma cells. Oncol Rep 2018; 40: 1233–42. doi: 10.3892/or.2018.6522WangRLiYChenYWangLWuQGuoYInhibition of RAD54B suppresses proliferation and promotes apoptosis in hepatoma cells20184012334210.3892/or.2018.6522Open DOISearch in Google Scholar
Ucuzian AA, Gassman AA, East AT, Greisler HP. Molecular mediators of angiogenesis. J Burn Care Res 2010; 31: 158–75. doi: 10.1097/BCR.0b013e3181c7ed82UcuzianAAGassmanAAEastATGreislerHPMolecular mediators of angiogenesis2010311587510.1097/BCR.0b013e3181c7ed82Open DOISearch in Google Scholar
Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249–57. doi: 10.1038/35025220CarmelietPJainRKAngiogenesis in cancer and other diseases20004072495710.1038/35025220Open DOISearch in Google Scholar
Katayama Y, Uchino J, Chihara Y, Tamiya N, Kaneko Y, Yamada T, et al. Tumor neovascularization and developments in therapeutics. Cancers 2019; 11. doi: 10.3390/cancers11030316KatayamaYUchinoJChiharaYTamiyaNKanekoYYamadaTTumor neovascularization and developments in therapeutics20191110.3390/cancers11030316Open DOISearch in Google Scholar
Chatterjee A, Paul S, Bisht B, Bhattacharya S, Sivasubramaniam S, Paul MK. Advances in targeting the WNT/β-catenin signaling pathway in cancer. Drug Discov Today 2022; 27: 82–101. doi: 10.1016/j.drudis.2021.07.007ChatterjeeAPaulSBishtBBhattacharyaSSivasubramaniamSPaulMKAdvances in targeting the WNT/β-catenin signaling pathway in cancer2022278210110.1016/j.drudis.2021.07.007Open DOISearch in Google Scholar
Li TH, Zhao BB, Qin C, Wang YY, Li ZR, Cao HT, et al. IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling. Cell Oncol 2021; 44: 1425–37. doi: 10.1007/s13402-021-00651-8LiTHZhaoBBQinCWangYYLiZRCaoHTIFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling20214414253710.1007/s13402-021-00651-8Open DOISearch in Google Scholar
Xueqin T, Jinhong M, Yuping H. Inhibin subunit beta A promotes cell proliferation and metastasis of breast cancer through Wnt/β-catenin signaling pathway. Bioengineered 2021; 12: 11567–75. doi: 10.1080/21655979.2021.1971028XueqinTJinhongMYupingHInhibin subunit beta A promotes cell proliferation and metastasis of breast cancer through Wnt/β-catenin signaling pathway202112115677510.1080/21655979.2021.1971028Open DOISearch in Google Scholar
Yan Y, Zhang Y, Li M, Zhang Y, Zhang X, Zhang X, et al. C644-0303, a small-molecule inhibitor of the Wnt/β-catenin pathway, suppresses colorectal cancer growth. Cancer Sci 2021; 112: 4722–35. doi: 10.1111/cas.15118YanYZhangYLiMZhangYZhangXZhangXC644-0303, a small-molecule inhibitor of the Wnt/β-catenin pathway, suppresses colorectal cancer growth202111247223510.1111/cas.15118Open DOISearch in Google Scholar
Song X, Wang S, Li L. New insights into the regulation of Axin function in canonical Wnt signaling pathway. Protein Cell 2014; 5: 186–93. doi: 10.1007/s13238-014-0019-2SongXWangSLiLNew insights into the regulation of Axin function in canonical Wnt signaling pathway201451869310.1007/s13238-014-0019-2Open DOISearch in Google Scholar
Machin P, Catasus L, Pons C, Muñoz J, Matias-Guiu X, Prat J. CTNNB1 mutations and beta-catenin expression in endometrial carcinomas. Hum Pathol 2002; 33: 206–12. doi: 10.1053/hupa.2002.30723MachinPCatasusLPonsCMuñozJMatias-GuiuXPratJCTNNB1 mutations and beta-catenin expression in endometrial carcinomas2002332061210.1053/hupa.2002.30723Open DOISearch in Google Scholar
Crawford HC, Fingleton B, Gustavson MD, Kurpios N, Wagenaar RA, Hassell JA, et al. The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Mol Cell Biol 2001; 21: 1370–83. doi: 10.1128/mcb.21.4.1370-1383.2001CrawfordHCFingletonBGustavsonMDKurpiosNWagenaarRAHassellJAThe PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors20012113708310.1128/mcb.21.4.1370-1383.2001Open DOISearch in Google Scholar
Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T. beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 1999; 155: 1033–8. doi: 10.1016/s0002-9440(10)65204-2BrabletzTJungADagSHlubekFKirchnerTbeta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer19991551033810.1016/s0002-9440(10)65204-2Open DOISearch in Google Scholar